Analysts: GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

3,343.05INR
23 Jan 2015
Change (% chg)

Rs189.05 (+5.99%)
Prev Close
Rs3,154.00
Open
Rs3,152.20
Day's High
Rs3,525.00
Day's Low
Rs3,149.40
Volume
130,958
Avg. Vol
15,903
52-wk High
Rs3,525.00
52-wk Low
Rs2,365.00

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- December 25 Jan 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 5 5 5 6
(4) UNDERPERFORM 5 5 6 6
(5) SELL 1 1 1 2
No Opinion 0 0 0 0
Mean Rating 3.31 3.31 3.36 3.44

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 1 47.40 47.40 47.40 --
Quarter Ending Jun-15 1 34.80 34.80 34.80 --
Year Ending Dec-15 9 30,434.00 32,415.60 27,102.00 33,366.50
Earnings (per share)
Year Ending Dec-15 9 68.77 85.50 57.70 94.38
LT Growth Rate (%) 1 16.80 16.80 16.80 --

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-10 5,833.20 5,819.90 13.30 0.23
Quarter Ending Jun-10 5,212.33 4,979.30 233.03 4.47
Quarter Ending Mar-10 5,193.00 5,411.00 218.00 4.20
Quarter Ending Dec-09 4,127.20 4,444.00 316.80 7.68
Quarter Ending Sep-09 5,023.25 5,118.10 94.85 1.89
Earnings (per share)
Quarter Ending Sep-10 18.70 18.70 0.00 0.00
Quarter Ending Jun-10 17.80 16.40 1.40 7.87
Quarter Ending Sep-09 15.60 16.70 1.10 7.05
Quarter Ending Jun-09 14.30 15.50 1.20 8.39
Quarter Ending Mar-09 15.00 14.80 0.20 1.33

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 47.40 47.40 47.40 47.40 --
Quarter Ending Jun-15 34.80 34.80 34.80 34.80 --
Year Ending Dec-15 30,434.00 30,434.00 30,510.60 30,574.20 33,366.50
Earnings (per share)
Year Ending Dec-15 68.77 68.77 70.38 71.13 94.38

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-15 0 0 0 0
Quarter Ending Jun-15 0 0 0 0
Year Ending Dec-15 0 0 0 0
Earnings
Year Ending Dec-15 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Motilal Oswal Securities Ltd.
$58.00
Provider: Axis Capital Limited
$35.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks